I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Favipiravir Use in COVID-19: Analysis of Suspected Adverse ..:
Kaur RJ
;
Charan J
;
Dutta S
...
https://www.dovepress.com/favipiravir-use-in-covid-19-analysis-of-suspected-adverse-drug-events--peer-reviewed-article-IDR. , 2020
Link:
https://doaj.org/article/b4a2c198e4644193a7cc4bc3f2c52..
RT Journal T1
Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:b4a2c198e4644193a7cc4bc3f2c52c29&Exemplar=1&LAN=DE A1 Kaur RJ A1 Charan J A1 Dutta S A1 Sharma P A1 Bhardwaj P A1 Lugova H A1 Krishnapillai A A1 Islam S A1 Haque M A1 Misra S PB Dove Medical Press YR 2020 K1 favipiravir K1 usage K1 sars-cov-2 K1 scrutiny K1 assumed K1 adverse drug events K1 described K1 world health organization K1 record K1 Infectious and parasitic diseases K1 RC109-216 JF https://www.dovepress.com/favipiravir-use-in-covid-19-analysis-of-suspected-adverse-drug-events--peer-reviewed-article-IDR LK http://dx.doi.org/https://doaj.org/article/b4a2c198e4644193a7cc4bc3f2c52c29 DO https://doaj.org/article/b4a2c198e4644193a7cc4bc3f2c52c29 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)